Literature DB >> 26870213

Mesonephric carcinoma of the uterine corpus: A report of two cases.

Jianguo Zhao1, Caiyan Liu2, J I Qi2, Pengpeng Qu2.   

Abstract

Mesonephric carcinoma of the uterine corpus is an extremely rare malignancy that originates from the mesonephric remnant of the female reproductive tract. There have been no previous reports of mesonephric carcinoma accompanied by a sarcomatous component. The current study presents two cases of uterine corpus mesonephric carcinoma with sarcomatous components that occurred in postmenopausal women. Immunohistochemically, the tumour cells were positive for vimentin and CD10. The tumours of these patients were located in the uterine myometrium; therefore, treatment was similar to that for endometrial cancer. Although the follow-up period was short in the current cases, no metastatic disease was identified in the second case and thus, this may increase clinical knowledge with regard to the biological behavior of these rare malignancies.

Entities:  

Keywords:  diagnosis; mesonephric carcinoma; sarcomatous component; treatment; uterine corpus

Year:  2015        PMID: 26870213      PMCID: PMC4727032          DOI: 10.3892/ol.2015.3886

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  5 in total

Review 1.  Second case of uterine mesonephric adenocarcinoma.

Authors:  A Marquette; P Moerman; I Vergote; F Amant
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

2.  Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.

Authors:  J Ordi; F F Nogales; A Palacin; M Márquez; J Pahisa; J A Vanrell; A Cardesa
Journal:  Am J Surg Pathol       Date:  2001-12       Impact factor: 6.394

Review 3.  Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature.

Authors:  Yoji Wani; Kenji Notohara; Choutatsu Tsukayama
Journal:  Int J Gynecol Pathol       Date:  2008-07       Impact factor: 2.762

Review 4.  Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus.

Authors:  Clara Montagut; Maribel Mármol; Victoria Rey; Jaume Ordi; Jaume Pahissa; Angeles Rovirosa; Pedro Gascón; Begoña Mellado
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

Review 5.  Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.

Authors:  Shiori Meguro; Masanori Yasuda; Michio Shimizu; Akira Kurosaki; Keiichi Fujiwara
Journal:  Diagn Pathol       Date:  2013-05-07       Impact factor: 2.644

  5 in total
  3 in total

1.  Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation.

Authors:  Brie Kezlarian; Stephanie Muller; Vitor Werneck Krauss Silva; Carlene Gonzalez; Daniel J Fix; Kay J Park; Rajmohan Murali
Journal:  Cancer Cytopathol       Date:  2019-07-18       Impact factor: 5.284

2.  Clinicopathologic and Molecular Characteristics of Mesonephric Adenocarcinoma Arising From the Uterine Body.

Authors:  Kiyong Na; Hyun-Soo Kim
Journal:  Am J Surg Pathol       Date:  2019-01       Impact factor: 6.394

3.  Mesonephric Adenocarcinoma of the Vagina Harboring TP53 Mutation.

Authors:  Hyunjee Lee; Hyunjin Kim; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.